v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Grant revenue $ 290 $ 526 $ 632 $ 851
Operating expenses:        
Research and development 16,620 9,275 30,952 16,727
General and administrative 7,709 5,514 15,551 11,392
Total operating expenses 24,329 14,789 46,503 28,119
Operating loss (24,039) (14,263) (45,871) (27,268)
Non-operating income (expense):        
Interest income 2,159 3,076 4,543 4,287
Interest and other expense (119) (23) (247) (52)
Other income from a related party (Note 3) 0 0 1,400 0
Equity in loss of affiliate 0 (4) (1) (6)
Total non-operating income, net 2,040 3,049 5,695 4,229
Net loss from continuing operations (21,999) (11,214) (40,176) (23,039)
Net gain (loss) from discontinued operations 514 (490) 514 (949)
Net loss $ (21,485) $ (11,704) $ (39,662) $ (23,988)
Basic and diluted loss per share:        
Loss from continuing operations, Basic $ (0.3) $ (0.17) $ (0.55) $ (0.4)
Loss from continuing operations, Diluted (0.3) (0.17) (0.55) (0.4)
Gain (loss) from discontinued operations, Basic 0.01 (0.01) 0.01 (0.01)
Gain (loss) from discontinued operations, Diluted 0.01 (0.01) 0.01 (0.01)
Basic loss per share (0.29) (0.18) (0.54) (0.41)
Diluted loss per share $ (0.29) $ (0.18) $ (0.54) $ (0.41)
Weighted average shares used in computing net loss per share:        
Basic 74,235 66,648 73,301 58,079
Diluted 74,235 66,648 73,301 58,079
Unrealized (loss) gain on available-for-sale securities $ (16) $ (0) $ 54 $ (0)
Comprehensive loss $ (21,501) $ (11,704) $ (39,608) $ (23,988)